Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
40%(2 trials)

Phase Distribution

Ph early_phase_1
1
13%
Ph phase_2
3
38%
Ph phase_1
3
38%
Ph phase_3
1
13%

Phase Distribution

4

Early Stage

3

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Early Phase 1First-in-human
1(12.5%)
Phase 1Safety & dosage
3(37.5%)
Phase 2Efficacy & side effects
3(37.5%)
Phase 3Large-scale testing
1(12.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Active(1)
Completed(5)
Terminated(1)
Other(1)

Detailed Status

Completed5
Not yet recruiting1
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (12.5%)
Phase 13 (37.5%)
Phase 23 (37.5%)
Phase 31 (12.5%)

Trials by Status

completed563%
not_yet_recruiting113%
unknown113%
withdrawn113%

Recent Activity

0 active trials
Showing 5 of 8
not_yet_recruitingearly_phase_1

Pilot Radioembolisation Clinical Trial Assessing Safety and Efficacy in Recurrent Glioma

NCT07712770
completedphase_2

SIR-Spheres® 90Y Microspheres Treatment of Uveal Melanoma Metastasized to Liver

NCT01473004
completedphase_2

Safety Study of Regorafenib and SIR-Spheres® Microspheres Radioembolization in Patients With Refractory Metastatic Colorectal Cancer With Liver Metastases

NCT02195011
completedphase_2

A Study of the Safety and Antitumoral Efficacy of Nivolumab After SIRT for the Treatment of Patients With HCC

NCT03380130
completedphase_1

CAR-T Hepatic Artery Infusions and Sir-Spheres for Liver Metastases

NCT02416466
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT07712770Early Phase 1

Pilot Radioembolisation Clinical Trial Assessing Safety and Efficacy in Recurrent Glioma

Not Yet Recruiting
NCT01473004Phase 2

SIR-Spheres® 90Y Microspheres Treatment of Uveal Melanoma Metastasized to Liver

Completed
NCT02195011Phase 2

Safety Study of Regorafenib and SIR-Spheres® Microspheres Radioembolization in Patients With Refractory Metastatic Colorectal Cancer With Liver Metastases

Completed
NCT03380130Phase 2

A Study of the Safety and Antitumoral Efficacy of Nivolumab After SIRT for the Treatment of Patients With HCC

Completed
NCT02416466Phase 1

CAR-T Hepatic Artery Infusions and Sir-Spheres for Liver Metastases

Completed
NCT01135056Phase 3

Study to Compare Selective Internal Radiation Therapy (SIRT) Versus Sorafenib in Locally Advanced Hepatocellular Carcinoma (HCC)

Unknown
NCT00712790Phase 1

Study of SIR-Spheres Plus Sorafenib as 1st Line Treatment for Non-resectable Primary Hepatocellular Carcinoma (HCC)

Completed
NCT01432119Phase 1

Phase 1 Trial With SIR-Spheres and Cetuximab +/- Erlotinib

Withdrawn

All 8 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
8